术后运动训练对合并慢阻肺的肺癌患者躯体功能和生活质量影响探究临床研究

注册号:

Registration number:

ChiCTR2200056709 

最近更新日期:

Date of Last Refreshed on:

2022-10-06 17:53:11 

注册时间:

Date of Registration:

2022-02-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

术后运动训练对合并慢阻肺的肺癌患者躯体功能和生活质量影响探究临床研究

Public title:

Effect of postoperative exercise training on physical function and quality of life of lung cancer patients with chronic obstructive pulmonary disease

注册题目简写:

English Acronym:

研究课题的正式科学名称:

术后运动训练对合并慢阻肺的肺癌患者躯体功能和生活质量影响探究临床研究

Scientific title:

Effect of postoperative exercise training on physical function and quality of life of lung cancer patients with chronic obstructive pulmonary disease

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

余中华 

研究负责人:

余中华 

Applicant:

Zhonghua Yu 

Study leader:

Zhonghua Yu 

申请注册联系人电话:

Applicant telephone:

+86 13628061753

研究负责人电话:

Study leader's
telephone:

+86 13628061753

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1850549417@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1850549417@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市武侯区国学巷37号

研究负责人通讯地址:

四川省成都市武侯区国学巷37号

Applicant address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

Study leader's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital, Sichuan University

研究负责人所在单位:

四川大学华西医院

Affiliation of the Leader:

West China Hospital, Sichuan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021/1600

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理审查委员会

Name of the ethic committee:

Biomedical ethics review committee of West China Hospital of Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-11-29 00:00:00

伦理委员会联系人:

陈诚

Contact Name of the ethic committee:

Cheng Chen

伦理委员会联系地址:

四川省成都市武侯区国学巷37号

Contact Address of the ethic committee:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital, Sichuan University

研究实施负责(组长)单位地址:

四川省成都市武侯区国学巷37号

Primary sponsor's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

成都

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

四川省成都市武侯区国学巷37号

Institution
hospital:

Sichuan University, West China Hospital

Address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

经费或物资来源:

Source(s) of funding:

none

研究疾病:

肺癌,慢性阻塞性肺病  

Target disease:

Lung cancer, chronic obstructive pulmonary disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1. 主要目的:探究术后运动训练对合并COPD肺癌术后患者躯体功能的影响 2. 次要目的:探究术后运动训练对合并COPD肺癌术后患者生活质量的影响  

Objectives of Study:

1. Main objective: To explore the effect of postoperative exercise training on the physical function of patients with lung cancer complicated with COPD; 2. Secondary objective: To explore the effect of postoperative exercise training on the quality of life of patients with lung cancer complicated with COPD.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 肺功能测试中患者FEVI低于预计值30%;
2. NYHA 心功能分级标准II、III、IV级;
3. 无法参加运动训练(如下肢功能障碍或偏瘫等);
4. 此前有肺部手术史;
5. 拒绝签署康复医学科康复治疗知情同意书。

Exclusion criteria:

1. FEV1 of patients in pulmonary function test was 30% lower than the expected value;
2. NYHA cardiac function classification standard II, III and IV;
3. Unable to participate in sports training (such as lower limb dysfunction or hemiplegia);
4. Previous history of lung surgery;
5. Refuse to sign the informed consent form of rehabilitation treatment in the Department of rehabilitation medicine.

研究实施时间:

Study execute time:

From 2022-02-16 00:00:00 To 2022-08-26 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-02-16 00:00:00 To 2022-07-29 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

42

Group:

Control Group

Sample size:

干预措施:

常规护理+常规临床干预

干预措施代码:

Intervention:

Routine nursing + routine clinical intervention

Intervention code:

组别:

运动组

样本量:

42

Group:

Exercise Group

Sample size:

干预措施:

常规护理+常规临床干预+运动训练

干预措施代码:

Intervention:

Routine nursing + routine clinical intervention + exercise training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

成都 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院 

单位级别:

三甲 

Institution
hospital:

Sichuan University, West China Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

EORTC生命质量测定量表QLQ-C30(V3.0)中文版

指标类型:

主要指标

Outcome:

EORTC quality of life scale QLQ-C30 (V3.0) Chinese version

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心肺运动试验

指标类型:

次要指标

Outcome:

Cardiopulmonary exercise test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺功能测试

指标类型:

次要指标

Outcome:

Pulmonary function test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

微信每日行走步数记录

指标类型:

次要指标

Outcome:

Wechat daily walking steps record

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表

指标类型:

次要指标

Outcome:

Hamilton Depression Scale, HAMD

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

Hamilton Anxiety Scale, HAMA

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法(与研究无关的医务人员使用电脑软件生成)

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method (generated by medical staff unrelated to the study using computer software)

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床实验注册中心公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

www.chictr.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

原始数据为纸质版,再由纸质版统计记录形成电子版

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The original data is in paper form, and then the paper statistical records form an electronic version

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-02-11 04:56:36